Great Basin Announces Business Update Call and Webcast

SALT LAKE CITY--()--Great Basin Scientific, Inc. (NASDAQ:GBSN, GBSNU), a molecular diagnostics company, announced today that it will report financial results for the second quarter ended June 30, 2015 after the market close on Wednesday, August 12, 2015. The Company also announced that it will host a business update call and webcast to discuss important operational progress and initiatives on the same day at 4:30 PM Eastern Time.

Great Basin invites all interested parties to join the call by dialing (877) 407-0789 for domestic participants and (201) 689-8562 for international participants. The call will also be broadcast live over the internet and can be accessed on the Investors section of the Company's website at www.gbscience.com.

A telephone replay will be available for one week following the call by dialing (877) 870-5176 for domestic participants and (858) 384-5517 for international participants. When prompted, please enter the replay pin number 13616805. For those who are not available to listen to the live webcast, the call will be archived for 90 days on the Great Basin website.

About Great Basin Scientific

Great Basin Scientific is a molecular diagnostics company that commercializes breakthrough chip-based technologies. The Company is dedicated to the development of simple, yet powerful, sample-to-result technology and products that provide fast, multiple-pathogen diagnoses of infectious diseases. The Company’s vision is to make molecular diagnostic testing so simple and cost-effective that every patient will be tested for every serious infection, reducing misdiagnoses and significantly limiting the spread of infectious disease. More information can be found on the company’s website at www.gbscience.com.

Contacts

ICR
Media:
Kate Ottavio Kent, 203-682-8276
Kate.Ottavio-Kent@icrinc.com
or
Investor Relations:
Bob Yedid, 646-277-1250
bob.yedid@icrinc.com

Release Summary

Great Basin Announces Business Update Call and Webcast

Contacts

ICR
Media:
Kate Ottavio Kent, 203-682-8276
Kate.Ottavio-Kent@icrinc.com
or
Investor Relations:
Bob Yedid, 646-277-1250
bob.yedid@icrinc.com